BMS-582949

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BMS-582949, covering 2010-03-02 to 2015-12-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis [Phase 2]